501 related articles for article (PubMed ID: 20504917)
1. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
[TBL] [Abstract][Full Text] [Related]
2. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
[TBL] [Abstract][Full Text] [Related]
3. Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.
Li W; Zhang L; Johnson JS; Zhijian W; Grieger JC; Ping-Jie X; Drouin LM; Agbandje-McKenna M; Pickles RJ; Samulski RJ
Mol Ther; 2009 Dec; 17(12):2067-77. PubMed ID: 19603002
[TBL] [Abstract][Full Text] [Related]
4. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.
Zhang L; Peeples ME; Boucher RC; Collins PL; Pickles RJ
J Virol; 2002 Jun; 76(11):5654-66. PubMed ID: 11991994
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
[TBL] [Abstract][Full Text] [Related]
8. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
[TBL] [Abstract][Full Text] [Related]
9. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus.
Cooney AL; Singh BK; Loza LM; Thornell IM; Hippee CE; Powers LS; Ostedgaard LS; Meyerholz DK; Wohlford-Lenane C; Stoltz DA; B McCray P; Sinn PL
Nucleic Acids Res; 2018 Oct; 46(18):9591-9600. PubMed ID: 30165523
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for the respiratory manifestations of cystic fibrosis.
Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
[TBL] [Abstract][Full Text] [Related]
11. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
12. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells.
Lei DC; Kunzelmann K; Koslowsky T; Yezzi MJ; Escobar LC; Xu Z; Ellison AR; Rommens JM; Tsui L-C ; Tykocinski M; Gruenert DC
Gene Ther; 1996 May; 3(5):427-36. PubMed ID: 9156804
[TBL] [Abstract][Full Text] [Related]
13. Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transfer.
Dupuit F; Chinet T; Zahm JM; Pierrot D; Hinnrasky J; Kaplan H; Bonnet N; Puchelle E
Hum Gene Ther; 1997 Aug; 8(12):1439-50. PubMed ID: 9287144
[TBL] [Abstract][Full Text] [Related]
14. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
[TBL] [Abstract][Full Text] [Related]
16. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
Harvey BG; Leopold PL; Hackett NR; Grasso TM; Williams PM; Tucker AL; Kaner RJ; Ferris B; Gonda I; Sweeney TD; Ramalingam R; Kovesdi I; Shak S; Crystal RG
J Clin Invest; 1999 Nov; 104(9):1245-55. PubMed ID: 10545523
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus infection disrupts monolayer integrity and function in cystic fibrosis airway cells.
Kong M; Maeng P; Hong J; Szczesniak R; Sorscher E; Sullender W; Clancy JP
Viruses; 2013 Sep; 5(9):2260-71. PubMed ID: 24056672
[TBL] [Abstract][Full Text] [Related]
18. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
Hay JG; McElvaney NG; Herena J; Crystal RG
Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
[TBL] [Abstract][Full Text] [Related]
19. A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs.
Cooney AL; Thornell IM; Singh BK; Shah VS; Stoltz DA; McCray PB; Zabner J; Sinn PL
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):747-754. PubMed ID: 31184507
[TBL] [Abstract][Full Text] [Related]
20. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
